EdgeTestMarket TodayOptions TodayIPO
Start free

FOSECOINDFoseco India Limited

Rs 5,721▼ -3.55%
Market closedEquity EOD 23 Oct
Compare
52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.46% up the range
Rs 4,300Rs 7,390
FOSECOIND price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 23 Oct
IndicatorsVolume

Loading FOSECOIND price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 4,312 cr
Larger than 67% of 64 peers
sector middle Rs 2,120 cr
P/EPrice to earnings: how many rupees investors pay for each rupee of profit the company made over the last twelve months. Compare it with similar companies rather than reading it alone.
42.9x
Higher than 68% of 56 peers
sector middle 27.3x
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
4.0x
Higher than 73% of 64 peers
sector middle 2.7x
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
9.4%
Around the middle of 60 peers
sector middle 9.8%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.00
Under 0.01
sector middle 0.22
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.4%
Around the middle of 64 peers
sector middle 0.3%
Sales growthHow much the latest quarter's sales grew against the same quarter a year earlier.
+47.2%
Higher than 88% of 57 peers
sector middle +24.9%
FY25 12.6%FY26 26.5%

Peers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 13 Aug 2026), sales rose 47.2% from a year earlier to Rs 231 cr and profit rose 69.0% to Rs 36.4 cr.

Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 20 results, the share rose on 10 and fell on 10, and moved by 3% or more on 12.

Q4 FY22Q1 FY24Q1 FY25Q1 FY26Q1 FY27

Q1 FY27: results filed 13 Aug 2026. The share went from its close on 12 Aug 2026 to its close on 14 Aug 2026 +2.25%.

What it owns and what it owes
Straight from the balance sheet in the company's filing. Net debt is borrowings less cash and liquid investments, so a negative figure means it holds more cash than debt.
as at 2026-06-30
Total assets
Rs 1,438 Cr
everything the company owns
Shareholders equity
Rs 1,079 Cr
75% of what it owns is funded by its owners
Cash and equivalents
Rs 139 Cr
cash and near-cash on hand
Net debt
Rs -139 Cr
holds more cash than debt
Debt to equity
0.00x
borrowings against the owners' money
Current ratio
2.87x
short-term assets against short-term dues

Companies file a balance sheet twice a year, not every quarter, so this is the most recent one published rather than the latest quarter.

The cash it actually made
Profit is an accounting figure; cash flow is what moved. Free cash flow is the cash from running the business less what was spent on plant and equipment, so it is what was left over to pay down debt or return to shareholders.
year to 2025-12-31
Cash from operations
Rs 98 Cr
cash the business itself threw off
Free cash flow
Rs 89 Cr
what was left after spending on the business
FCF margin
13.8%
free cash for every Rs 100 of sales
Cash vs profit
1.30x
every rupee of profit arrived as cash, or more

Cash flow is reported for the year to date, so this covers the full period ending 2025-12-31 rather than a single quarter.

Where every Rs 100 of sales goes
From the company's own yearly results. Each year is scaled to that year's sales, so you compare shares, not size: how much went on running costs, depreciation, interest and tax, and how much was left as profit.
4 financial years
Sales, last 12 months
Rs 771 Cr
Profit, last 12 months
Rs 102 Cr
Earnings per share
Rs 133.4
Profit growth (qtr, YoY)
+69.04%

Of every Rs 100 of sales in FY26, Rs 80 went on running costs, Rs 2.7 on depreciation, Rs 0.0 on interest and Rs 4.8 on tax; Rs 12 was left as profit.

FY22
87
10
FY24
85
15
FY25
82
14
FY26
80
12
Sales (Rs 100)Other incomeRunning costsDepreciationInterestTaxProfitOther gainsOther items

Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.

How fast it has grown
Compound growth per year in sales, profit and earnings per share between financial years, from the company's own results. A span appears only if our filings cover both ends of it.
Sales
Latest qtr
+47.2%
Profit
Latest qtr
+69.0%

Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.

Health check, year by year
Margins, returns, debt and interest cover for each financial year. Each row is coloured against this company's own usual level, so you see what is improving and what is slipping.
MeasureFY22FY24FY25FY26
Sales growthSales against the previous financial year.--12.6%26.5%
Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales.13.3%15.1%17.7%19.8%
Net marginProfit after everything, per Rs 100 of sales.10.2%15.3%14.3%12.4%
Interest coverHow many times operating profit covers the interest bill. Higher is safer.-974x532x602x

Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).

Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Specialty Chemicals · 91
P/E42.89vs 28.89 median
Cheapest: PLASTIBLEN 9.79Priciest: OAL 595.31
Net margin13.17%vs 6.64% median
Lowest: DIAMINESQ -24.79%Highest: SUDEEPPHRM 27.18%
Revenue growth47.16%vs 25.1% median
Lowest: ALKALI -14.78%Highest: FCL 174.77%
Compared against
AARTIINDAARTISURFACCENTMICACIAETHERAGASTYAENALKALIALKYLAMINEAMALAMBANIORGOANURASARVEEATULBALAMINESBASFBIOPOLBLACKROSECAMLINFINECHEMBONDCHEMBONDCHCHEMCONCHEMCRUXCHEMPLASTSCLEANDAICHIDDEVPLSTIKDEEPDEEPAKNTRDIAMINESQDMCCDSFCLDYNPROELANTASEPIGRALEXCELINDUSFAIRCHEMORFCLFINEORGFLUOROCHEMGALAXYSURF

Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.

Peers side by side
Every company in the same NSE industry group that we hold figures for, largest first. Tap any heading to sort by it. The same figures as the At a glance tiles, worked out the same way for every company.
Specialty Chemicals · 40 shown
Company
PIDILITIND
Pidilite Industries Limited
1.51 L cr57.3x14.0x24.2%28.5%0.0117.4%+21.3%1.01%
SRF
SRF Limited
68,473 cr30.0x4.5x14.9%-0.3412.5%+34.7%0.39%
FLUOROCHEM
Gujarat Fluorochemicals Limited
46,597 cr76.1x5.9x7.7%10.2%0.2811.5%+24.0%0.07%
NAVINFLUOR
Navin Fluorine International Limited
39,339 cr49.8x9.9x19.9%18.7%0.3121.7%+44.1%0.17%
DEEPAKNTR
Deepak Nitrite Limited
19,734 cr25.2x3.4x13.3%10.8%0.269.1%+36.4%0.52%
AETHER
Aether Industries Limited
18,748 cr79.5x7.6x9.6%12.2%0.1819.2%+52.4%0.00%
ATUL
Atul Limited
16,416 cr21.3x2.5x11.8%-0.0211.3%+20.9%0.45%
AARTIIND
Aarti Industries Limited
15,508 cr29.3x2.6x8.9%8.5%0.835.9%+42.5%0.23%
FINEORG
Fine Organic Industries Limited
15,483 cr35.3x5.8x16.4%20.2%0.0217.7%+18.0%0.22%
BASF
BASF India Limited
13,290 cr20.6x3.4x16.3%13.1%0.004.0%+24.5%0.65%
PRIVISCL
Privi Speciality Chemicals Limited
12,696 cr47.8x9.0x23.7%25.1%0.7012.8%+19.2%0.15%
ANURAS
Anupam Rasayan India Limited
12,542 cr71.6x3.8x4.9%7.5%0.398.9%+34.8%0.12%
VINATIORGA
Vinati Organics Limited
11,105 cr24.8x3.5x14.2%17.7%0.0018.8%+28.4%0.70%
SUDEEPPHRM
Sudeep Pharma Limited
10,913 cr58.7x12.3x20.4%24.2%0.1727.2%-0.00%
JUBLINGREA
Jubilant Ingrevia Limited
9,516 cr31.0x3.0x9.9%10.8%0.256.6%+25.3%0.83%
ALKYLAMINE
Alkyl Amines Chemicals Limited
8,362 cr37.2x5.5x14.7%14.6%0.0013.6%+30.2%0.61%
GALAXYSURF
Galaxy Surfactants Limited
7,876 cr22.3x2.9x12.9%12.7%0.066.2%+39.4%0.27%
CLEAN
Clean Science and Technology Limited
7,583 cr32.6x4.8x14.7%19.2%0.0023.7%+10.5%0.84%
NEOGEN
Neogen Chemicals Limited
5,952 cr163.6x7.3x4.4%6.8%1.633.8%+34.0%0.04%
BALAMINES
Balaji Amines Limited
5,923 cr28.9x3.0x9.8%10.2%0.0613.8%+27.2%0.60%
ACI
Archean Chemical Industries Limited
5,907 cr60.7x3.0x5.0%7.8%0.248.6%+11.9%0.63%
FOSECOIND
Foseco India Limited
4,312 cr42.9x4.0x9.4%-0.0013.2%+47.2%0.37%
LXCHEM
Laxmi Organic Industries Limited
4,171 cr33.2x2.1x6.3%4.4%0.274.0%+39.8%0.33%
YASHO
Yasho Industries Limited
4,013 cr69.6x9.0x13.0%11.3%1.226.1%+54.9%0.02%
EPIGRAL
Epigral Limited
3,861 cr14.3x1.7x12.2%14.8%0.2510.3%+16.3%0.47%
VISHNU
Vishnu Chemicals Limited
3,812 cr25.4x3.6x13.9%16.2%0.498.8%+24.9%0.05%
TATVA
Tatva Chintan Pharma Chem Limited
3,671 cr71.4x4.7x6.6%7.6%0.159.2%+43.0%0.06%
STYRENIX
Styrenix Performance Materials Limited
3,407 cr12.5x2.5x20.0%12.8%0.237.8%+7.1%2.77%
CHEMPLASTS
Chemplast Sanmar Limited
2,896 cr-1.6x-22.3%-4.1%1.11-9.2%+2.3%0.00%
JUBLCPL
Jubilant Agri and Consumer Products Limited
2,762 cr21.6x6.0x28.2%34.9%0.066.6%+18.4%0.00%
DDEVPLSTIK
Ddev Plastiks Industries Limited
2,511 cr11.8x2.5x21.1%28.9%0.056.7%+28.6%0.93%
NOCIL
NOCIL Limited
2,457 cr37.3x1.4x3.7%4.1%0.004.8%+19.9%1.38%
ROSSARI
Rossari Biotech Limited
2,297 cr15.3x1.7x11.3%15.3%0.315.9%+28.2%0.12%
OAL
Oriental Aromatics Limited
1,943 cr595.3x2.9x0.8%6.2%0.610.5%+15.2%0.09%
SHK
S H Kelkar and Company Limited
1,737 cr19.5x1.3x6.5%9.6%0.623.6%+14.1%1.59%
VIDHIING
Vidhi Specialty Food Ingredients Limited
1,591 cr29.9x4.8x16.2%20.9%0.1812.1%+66.4%1.41%
CAMLINFINE
Camlin Fine Sciences Limited
1,547 cr366.1x1.5x0.1%2.9%0.670.0%+22.7%0.00%
PAUSHAKLTD
Paushak Limited
1,531 cr-3.1x-8.7%0.16--0.40%
PLATIND
Platinum Industries Limited
1,234 cr24.5x2.8x10.8%14.9%0.0111.1%-5.6%0.00%
VALIANTORG
Valiant Organics Limited
1,157 cr21.3x1.5x7.2%7.0%0.337.1%+13.3%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
4 years · 20 quarters
Full financial years - the long arc of the business.
Sales growth
+26.0%
a year, 3 years
Profit growth
+34.5%
a year, 3 years
Operating margin
19.8%
latest year
Sales by financial yearRs 697 Cr
Net profit by financial yearRs 87 Cr
FY224 full years · hover a yearFY26

Operating margin has gone from 13.3% to 19.8% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.

Dividends paid
Cash paid per share, from the exchange's corporate-action record, restated to today's share count across bonuses and splits. Dates shown are ex-dates: you must own the shares before that date to receive the payment.
0.44% yield
Rs 440 / year
Paid 11 of 11 yrs
on Rs 1 lakh at today's price · 0.44% yield · Rs 25/share
What each year paid, on Rs 1 lakh
350
472
437
87
175
437
437
437
437
437
17
18
19
20
21
22
23
24
25
26*
* 2026 so far - more may still be declared this year

2026 has paid Rs 25.00 per share, about Rs 437 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 8
DatePartySideQtyPriceValue
2026-08-27MORGANITE CRUCIBLE LIMITEDSELL5,90,7445,897Rs 348.36 Cr
2026-08-27MORGANITE CRUCIBLE LIMITEDSELL5,90,7445,897Rs 348.36 Cr
2026-08-27MORGAN TERRASSEN B VSELL5,60,0565,897Rs 330.27 Cr
2026-08-27MORGAN TERRASSEN B VSELL5,60,0565,897Rs 330.27 Cr
2026-08-27SBI MUTUAL FUNDBUY3,22,2975,897Rs 190.06 Cr
2026-08-27SBI MUTUAL FUNDBUY3,22,2975,897Rs 190.06 Cr
2026-08-27MIRAE ASSET MUTUAL FUNDBUY2,91,7935,897Rs 172.07 Cr
2026-08-27MIRAE ASSET MUTUAL FUNDBUY2,91,7935,897Rs 172.07 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 23 Oct
RSI (14) - momentum
30.3Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
41.7%Near average
today 41.7%20d avg 48.4%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-7.03%
vs 200-DMA
+9.42%
1-month
-12.82%
3-month
+13.69%
1-year
-2.36%
Realized vol (30d)
37.6%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on FOSECOIND?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.